Zobrazeno 1 - 10
of 37
pro vyhledávání: '"D. J. Goodman"'
Autor:
H, Gock, E, Salvaris, L, Murray-Segal, P, Mottram, W, Han, M J, Pearse, D J, Goodman, P J, Cowan, A J, d'Apice
Publikováno v:
Xenotransplantation. 7(4)
Pig-to-primate vascularized xenografts undergo hyperacute rejection (HAR). This results from pre-formed xenoreactive antibodies directed against galactose-alpha1,3-galactose (alphaGal) in the donor organ and activation of the complement cascade. We d
Autor:
J P, Fryer, J R, Leventhal, W, Pao, C, Stadler, M, Jones, T, Walsh, R, Zhong, Z, Zhang, H, Wang, D J, Goodman, M, Kurek, A J, d'Apice, B, Blondin, D, Ivancic, F, Buckingham, D, Kaufman, M, Abecassis, F, Stuart, B E, Anderson
Publikováno v:
Transplantation. 70(5)
Acute vascular xenograft rejection (AVXR), also termed delayed xenograft rejection (DXR), occurs when hyperacute rejection (HAR) is prevented by strategies directed at xenoreactive natural antibodies and/or complement activation. We have hypothesized
Publikováno v:
Transplantation. 66(9)
Inhibition of complement in small animal models of xenotransplantation has demonstrated graft infiltration with natural killer (NK) cells and monocytes associated with endothelial cell (EC) activation. We have previously demonstrated that human NK ce
Publikováno v:
Transplantation. 63(3)
Monocytes (Mo) are thought to be important effector cells in early xenograft rejection. Effects of Mo-endothelial cell (EC) interactions on EC activation in vitro were studied by coculturing human Mo or human monocytoid cell lines, U937 and THP-1, wi
Publikováno v:
Transplantation. 62(7)
Activated natural killer (NK) cells have been found in rejecting discordant xenografts and may contribute to endothelial cell (EC) activation and damage. The transcription of genes associated with EC activation, such as E-selectin and interleukin (IL
Publikováno v:
Transplantation proceedings. 28(2)
Publikováno v:
Transplantation proceedings. 28(2)
Publikováno v:
Transplantation. 61(5)
Endothelial cell (EC) activation is a consistent feature of discordant xenograft rejection. Treatment of xenograft recipients with complement inhibitors and xenoreactive natural antibody depletion leads to delayed xenograft rejection associated with
Autor:
F H, Bach, S C, Robson, C, Ferran, M, Millan, J, Anrather, C, Kopp, B, Lesnikoski, D J, Goodman, W W, Hancock, C, Wrighton
Publikováno v:
Transplantation proceedings. 27(1)
Autor:
D. J. Goodman
Publikováno v:
Transplantation Journal. 90:533